| 961/2088 | US=64 / Biol/Mol Costello LC, Franklin RB. Integration of genetic, proteomic, and metabolic approaches in tumor cell metabolism. In: Singh KK, Costello LC. Mitochondria and cancer. New York: Spriger, 2009. p. 79-92. ISBN 978-0-387-84834-1. METABOLICA NO METABOLISMO DAS CELULAS TUMORAIS; RELACOES DE ATIVIDADE CELULAR; METABOLISMO CELULAR E MALIGNIDADE; CELULA MALIGNA DITA O SEU METABOLISMO; METABOLICA DE CELULAS MALIGNAS; IMPORTANTES CELULARES BIOQUIMICAS; METABOLICA RELACOES; MITOCONDRIAIS ENZIMATICOS; METABOLISMO ANALISES; CONCEITO DE GENES METABOLICOS; PROTEOMICA PARA O METABOLISMO DAS CELULAS TUMORAIS INTERMEDIARIO |
| 962/2088 | US=64 / Biol/Mol Pastorino JG, Hoek JB. Integration of energy metabolism and control of apoptosis in tumor cells. In: Singh KK, Costello LC. Mitochondria and cancer. New York: Spriger, 2009. p. 103-29. ISBN 978-0-387-84834-1. INTEGRACAO DO METABOLISMO DE ENERGIA; CONTROLO DA APOPTOSE EM CELULAS TUMORAIS; CONTROLO DO METABOLISMO ENERGETICO; LIGACAO DA HEXOQUINASE MITOCONDRIAL; METABOLISMO DA CELULA CANCEROSA; APOPTOSE EM CELULAS TUMORAIS |
| 963/2088 | US=64 / Biol/Mol Corcoran CA, Huang Y, Sheikh MS. Energy generating pathways and the tumor suppressor p53. In: Singh KK, Costello LC. Mitochondria and cancer. New York: Spriger, 2009. p. 131-50. ISBN 978-0-387-84834-1. ENERGIA VIAS GERADORAS; SUPRESSOR TUMORAL P53; REGULACAO DE PROTEINAS ENVOLVIDAS NA GLICOLISE POR 53; REGULACAO DAS PROTEINAS ENVOLVIDAS NA RESPIRACAO AEROBIA POR 53 |
| 964/2088 | US=64 / Biol/Mol Baysal BE. Mitochondrial tumor suppressors. In: Singh KK, Costello LC. Mitochondria and cancer. New York: Spriger, 2009. p. 151-62. ISBN 978-0-387-84834-1. MITOCONDRIAIS SUPRESSORES DE TUMOR; MITOCONDRIAL; PAPEL DAS MITOCONDRIAS NO CANCER; ENZIMAS DO CICLO DE KREBS; SUSCEPTIBILIDADE HERDADA TUMOR; MECANISMO DE PATOGENESE EM HLRCC |
| 965/2088 | US=66 / Câncer Baeten CIM. Biomarkers of cell proliferation in carcinomas: detection of angiogenesis and infiltrated leukocytes. In: Kozlov SV. Inflammation and cancer: methods and protocols: experimental models and practical approaches. New York: Humana Press, 2009. p. 61-73. (Methods in Molecular Biology n.511 - Springer Protocols) ISBN 978-1-934115-14-5. CITOMETRIA DE FLUXO; BIOMARCADORES DE PROLIFERACAO CELULAR EM CARCINOMAS; DETECCAO DE ANGIOGENESE; LEUCOCITOS INFILTRADOS; TUMOR; ANGIOGENESE; LEUCOCITOS; EXPRESSAO ADESAO MOLECULAR |
| 966/2088 | US=66 / Câncer Petrella BL. Assessment of local proteolytic milieu as a factor in tumor invasiveness and metastasis formation: in vitro collagen degradation and invasion assays. In: Kozlov SV. Inflammation and cancer: methods and protocols: experimental models and practical approaches. New York: Humana Press, 2009. p. 75-84. (Methods in Molecular Biology n.511 - Springer Protocols) ISBN 978-1-934115-14-5. INVASAO TUMORAL; DEGRADACAO DO COLAGENO IN VITRO; TESTES DE INVASAO; COLAGENO; DEGRADACAO; DESTRUICAO; ENSAIO; MMP; INVASAO TUMORAL; METASTASE |
| 967/2088 | US=66 / Câncer Barsov EV. Selective immortalization of tumor-specific T cells to establish long-term T-cell lines maintaining primary cell characteristics. In: Kozlov SV. Inflammation and cancer: methods and protocols: experimental models and practical approaches. New York: Humana Press, 2009. p. 143-58. (Methods in Molecular Biology n.511 - Springer Protocols) ISBN 978-1-934115-14-5. IMORTALIZACAO SELECTIVA DE CELULAS T ESPECIFICAS DO TUMOR PARA ESTABELECER A LONGO PRAZO DE CELULAS T LINHAS MANUTENCAO DAS CARACTERISTICAS DE CELULAS PRIMARIAS; ANTIGENIO-ESPECIFICA DE CELULAS T; TUMOR-CELULAS T ESPECIFICAS; VECTOR RETROVIRAL; IMORTALIZACAO; SENESCENCIA; TELOMERASE RESERVA-TRANSCRIPTASE |
| 968/2088 | US=66 / Câncer Zhu Q, Weiner AJ. A hepatitis C virus xenograft mouse efficacy model. In: Kozlov SV. Inflammation and cancer: methods and protocols: experimental models and practical approaches. New York: Humana Press, 2009. p. 323-31. (Methods in Molecular Biology n.511 - Springer Protocols) ISBN 978-1-934115-14-5. VIRUS DA HEPATITE C. XENOENXERTO; VIRUS DA HEPATITE C; MURINO; MODELO DE TUMOR; ANTIVIRAL; REPLICON |
| 969/2088 | US=67 / Câncer Pacak K, Eisenhfer G, Lenders JWM, Koch CA. Pheochromocytoma. In: Bar RS, editor. Early diagnosis and treatment of endocrine disorders. New Jersey: Humana Press, 2009. p. 297-311. ISBN 978-1-58829-193-6. FEOCROMOCITOMA; FEOCROMOCITOMA. DIAGNOSTICO; FEOCROMOCITOMA. TRATAMENTO; TUMOR NEUROENDOCRINO DA MEDULA DAS GLANDULAS SUPRA-RENAIS |
| 970/2088 | US=78 / Câncer Stephens FO, Aigner KR. Cancers of bladder and kidneys. In: ___. Basics of oncology. New York: Springer, 2009. p. 245-50. ISBN 978-3-540-92924-6. CANCER; BEXIGA; RINS; TUMOR DE WILM'S; NEFROBLASTOMA; HIPERNEFROMA; ADENOCARCINOMA RENAL |
| 971/2088 | US=78 / Câncer Stephens FO, Aigner KR. Malignant tumours of bone and cartilage. In: ___. Basics of oncology. New York: Springer, 2009. p. 291-7. ISBN 978-3-540-92924-6. CANCER; OSSO; CARTILAGEM; OSTEOSARCOMA; OSTEOCLASTOMA; TUMOR DE EWING; CONDROSARCOMA |
| 972/2088 | US=85 / Biol/Mol Plantivaux A, Szegezdi E, Samali A, Egan L. Is there a role for nuclear factor kB in tumor necrosis factor-related apoptosis-inducing ligand resistance?. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 38-49. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5. CANCER; APOPTOSE; RESISTENCIA; INIBIDORES DE PROTEASSOMA; SUPER-REPRESSOR; MTOR; TRAIL; NF-KB |
| 973/2088 | US=85 / Biol/Mol Corazza N, Kassahn D, Jakob S, Badmann A, Brunner T. TRAIL-induced apoptosis: between tumor therapy and immunopathology. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 50-8. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5. TRAIL; HEPATOCITOS; APOPTOSE; TUMOR; LESAO HEPATICA; BIM; JUN QUINASE |
| 974/2088 | US=87 / Biol/Mol Conrad K, Bartsch H, Canzler U, Pilarsky C, Grutzmann R, Bachmann M. Search for and identification of novel tumor-associated autoantigens. In: Grützmann R, Pilarsky C. Cancer gene profiling: methods and protocols. New York: Humana Press, 2009. p. 213-30. (Methods in Molecular Biology, 576) ISBN 978-1-934115-76-3. AUTO-ANTIGENIOS ASSOCIADOS A TUMORES; IMMUNOSCREENING; ANTIGENOS ASSOCIADOS A TUMORES; FAGO LAMBDA; BIBLIOTECA DE CDNA |
| 975/2088 | US=87 / Biol/Mol Mogck U, Goekkurt E, Stoehlmacher J. The EGFR pathway as an example for genotype: phenotype correlation in tumor genes. In: Grützmann R, Pilarsky C. Cancer gene profiling: methods and protocols. New York: Humana Press, 2009. p. 341-50. (Methods in Molecular Biology, 576) ISBN 978-1-934115-76-3. VIA DE EGFR; GENOTIPO; FENOTIPO; CORRELACAO DE GENES DE TUMORES; KRAS; EGFR; POLIMORFISMO; GENOTIPO; CANCER COLORETAL |
| 976/2088 | US=89 / Biol/Mol Gillet JP, Macadangdang B, Fathke RL, Gottesman MM, Kimchi-Sarfaty C. The development of gene therapy: from monogenic recessive disorders to complex diseases such as cancer. In: Walther W, Stein US. Gene therapy of cancer: methods and protocols. 2ª ed. New Jersey: Humana Press, 2009. p. 5-54. (Methods in Molecular Biology, 542) ISBN 978-1-59745-561-9. TERAPIA ANTIANGIOGENICA; TERAPIA GENICA; SISTEMAS DE LIBERACAO DE GENES; SILENCIAMENTO GENICO; HISTORIA DE TERAPIA GENICA; IMUNOTERAPIA; VIRUS ONCOLITICOS; TERAPIA GENE SUICIDA; SUPRESSORES DE TUMOR |
| 977/2088 | US=89 / Biol/Mol Alemany R. Designing adenoviral vectors for tumor-specific targeting. In: Walther W, Stein US. Gene therapy of cancer: methods and protocols. 2ª ed. New Jersey: Humana Press, 2009. p. 57-74. (Methods in Molecular Biology, 542) ISBN 978-1-59745-561-9. |
| 978/2088 | US=89 / Biol/Mol Jia LJ, Hua ZC. Development of bacterial vectors for tumor-targeted gene therapy. In: Walther W, Stein US. Gene therapy of cancer: methods and protocols. 2ª ed. New Jersey: Humana Press, 2009. p. 131-54. (Methods in Molecular Biology, 542) ISBN 978-1-59745-561-9. VIAS DE ADMINISTRACAO; ANTI-ANGIOGENESE; VETOR BACTERIANA; TERAPIA GENICA DO CANCER; CITOCINA; EXPRESSAO DO GENE; TERAPIA PRO-DROGA; RNA DE INTERFERENCIA; DIRECIONAMENTO AO TUMOR |
| 979/2088 | US=89 / Biol/Mol Hao H, Zhou HS, McMasters KM. Chemosensitization of tumor cells: inactivation of nuclear factor-kappa B associated with chemosensitivity in melanoma cells after combination treatment with E2F-1 and doxorubicin. In: Walther W, Stein US. Gene therapy of cancer: methods and protocols. 2ª ed. New Jersey: Humana Press, 2009. p. 301-13. (Methods in Molecular Biology, 542) ISBN 978-1-59745-561-9. CANCER; QUIMIOSSENSIBILIZACAO; CELULAS TUMORAIS; FATOR NUCLEAR-KAPPA; QUIMIOSENSIBILIDADE; MELANOMA; E2F-1; DOXORRUBICINA; APOPTOSE; MOBILIDADE ELETROFORETICA |
| 980/2088 | US=89 / Biol/Mol Griffith TS. Induction of tumor cell apoptosis by trail gene therapy. In: Walther W, Stein US. Gene therapy of cancer: methods and protocols. 2ª ed. New Jersey: Humana Press, 2009. p. 315-34. (Methods in Molecular Biology, 542) ISBN 978-1-59745-561-9. INDUCAO DE APOPTOSE; TUMOR; TERAPIA GENETICA; TRAIL; ADENOVIRUS; APOPTOSE; TRANSFERENCIA DE GENES |